Heron Bay Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,978
Closed -$2.17M 127
2024
Q4
$2.17M Sell
14,978
-482
-3% -$74.7K 0.45% 44
2024
Q3
$2.51M Sell
15,460
-3,283
-18% -$523K 0.53% 43
2024
Q2
$2.74M Sell
18,743
-27,551
-60% -$4.1M 0.58% 41
2024
Q1
$7.32M Sell
46,294
-222
-0.5% -$35.3K 1.55% 24
2023
Q4
$7.29M Buy
46,516
+6,997
+18% +$1.07M 1.69% 23
2023
Q3
$6.16M Sell
39,519
-1,126
-3% -$186K 1.66% 24
2023
Q2
$6.73M Buy
40,645
+3,817
+10% +$616K 1.87% 22
2023
Q1
$5.71M Buy
36,828
+14,257
+63% +$2.3M 2.22% 15
2022
Q4
$3.99M Buy
22,571
+1,810
+9% +$313K 2.47% 18
2022
Q3
$3.39M Buy
20,761
+555
+3% +$93.9K 2.31% 17
2022
Q2
$3.59M Sell
20,206
-7,103
-26% -$1.27M 2.18% 16
2022
Q1
$4.84M Buy
27,309
+239
+0.9% +$40.7K 2.38% 16
2021
Q4
$4.63M Buy
27,070
+182
+0.7% +$29.8K 2.28% 15
2021
Q3
$4.34M Buy
26,888
+93
+0.3% +$15.9K 2.24% 19
2021
Q2
$4.41M Buy
26,795
+627
+2% +$104K 2.44% 15
2021
Q1
$4.3M Buy
26,168
+739
+3% +$120K 2.56% 12
2020
Q4
$4M Buy
+25,429
New +$3.75M 2.61% 11

Other funds holding JNJ

Heron Bay Capital Management's JNJ Position: Q1 2025 in Review

Heron Bay Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 14,978 shares — an estimated $2.17M sold.

Heron Bay Capital Management first reported a position in JNJ in Q4 2020 and held it in 17 quarters. The position peaked at $7.32M in Q1 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Heron Bay Capital Management reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Heron Bay Capital Management sold 14,978 Johnson & Johnson shares in Q1 2025, an estimated $2.17M.
  • Heron Bay Capital Management first reported a position in Johnson & Johnson in Q4 2020 and held it in 17 quarters.
  • Heron Bay Capital Management's Johnson & Johnson position peaked at $7.32M in Q1 2024.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Heron Bay Capital Management's 13F filing for Q1 2025, filed 13 May 2025.